Detalles de la búsqueda
1.
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
N Engl J Med
; 386(5): 437-448, 2022 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35045221
2.
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.
Gynecol Oncol
; 184: 168-177, 2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38325276
3.
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Cancer
; 129(12): 1846-1855, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37060236
4.
Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: a stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601.
Int J Gynecol Cancer
; 33(6): 929-936, 2023 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36759001
5.
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO).
Int J Mol Sci
; 24(13)2023 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37446361
6.
Neural stem cells in the adult olfactory bulb core generate mature neurons in vivo.
Stem Cells
; 39(9): 1253-1269, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33963799
7.
Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study.
Int J Gynecol Cancer
; 31(11): 1428-1436, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34610971
8.
An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.
Gynecol Oncol
; 159(3): 721-731, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32988624
9.
Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy.
Oncologist
; 24(8): e784-e792, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30470691
10.
Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.
Anticancer Drugs
; 30(6): 628-635, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31008727
11.
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis.
Oncologist
; 20(2): 111-2, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25601966
12.
Distinct human T-lymphocyte responses triggered by Porphyromonas gingivalis capsular serotypes.
J Clin Periodontol
; 41(1): 19-30, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24117627
13.
Activation of RANKL-induced osteoclasts and memory T lymphocytes by Porphyromonas gingivalis is serotype dependant.
J Clin Periodontol
; 41(5): 451-9, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24476556
14.
Intrinsic cues and hormones control mouse mammary epithelial tree size.
FASEB J
; 26(9): 3844-53, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22683848
15.
Safety of bevacizumab and olaparib as frontline maintenance therapy in advanced ovarian cancer: expert review for clinical practice.
Front Oncol
; 13: 1304303, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38348122
16.
Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors.
Cancers (Basel)
; 15(7)2023 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046661
17.
Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature.
Front Oncol
; 13: 1158981, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37213307
18.
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.
Clin Transl Oncol
; 25(7): 2090-2098, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36708371
19.
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.
Eur J Cancer
; 182: 3-14, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36706655
20.
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.
J Clin Oncol
; 41(35): 5400-5410, 2023 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37669480